Firm Newsletter, Spring 2008

May 1, 2008

By: Martha S. Helmreich , Michael A. Morse , Kevin E. Raphael , Paul Kenneth Vey

Articles In This Issue:

1. Criminal and Civil Liability to Physicians and Other Health Care Providers For the Off-Label Marketing of FDA-Approved Drugs or Devices: An Emerging Trend?
2. Mandatory Rules For Pennsylvania Medical Facilities For Reporting Medical Errors, Adverse Events And Device Failures
3. Hospital mergers Receive Closer Antitrust  Scrutiny From Federal Trade Commission
4. M-Care Iinfection Control: A Litigation Threat?
5. UPDATE: Federal Pre-emption Of State Tort Claims Involving Medical Devices And Pharmaceutical Products

Related Information:

News & Events

Related News

Nineteen Pietragallo Attorneys Recognized by The Best Lawyers in America® 2021
August 20, 2020
Pietragallo Gordon Alfano Bosick & Raspanti LLP, a business and litigation law firm with five offices across Pennsylvania, Ohio, and West Virginia, is proud to announce that nineteen of our distinguished attorneys have been recognized in The Best Lawyers in America® 2021 edition. Read More
New on the White Collar Blog: An Educational Institution’s Survival Guide for the Final Title IX Regulations
May 18, 2020
On May 6, 2020 the U.S. Department of Education (DOE) released the long-awaited final Title IX regulations.  The Final Regulations provide specific guidance to colleges and universities on how they must respond to allegations of sexual misconduct and other Title IX covered conduct.  Read More
View More News & Events